Always Remember - Buy The Dip

Sentiment Analysis For HBIO

The news is currently generally neutral for HBIO.

Based on TextBlob analysis of Yahoo! Finance news summaries for HBIO on 2015-09-03.

Yahoo! Finance News for HBIO

Why Harvard Bioscience (HBIO) Could Be Positioned for a Slump - Tale of the Tape
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid

Mid-Day Market Update: Meadowbrook Insurance Shares Jump On Acquisition News; Crude Oil Drops Over 2%
Midway through trading Wednesday, the Dow traded up 0.20 percent to 18,018.07 while the NASDAQ climbed 0.41 percent to 4,796.77. The S&P also rose, gaining 0.12 percent to 2,082.89. Leading and Lagging Sectors

Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update
Toward the end of trading Wednesday, the Dow traded down 0.20 percent to 17,947.63 while the NASDAQ slipped 0.10 percent to 4,772.89. The S&P also fell, dropping 0.27 percent to 2,074.82. Leading and Lagging Sectors

Affymetrix, Binding Site Group Ink Distribution Deal - Analyst Blog
Provider of life science tools and molecular diagnostic products, Affymetrix Inc. ( AFFX ), recently announced that its eBioscience business has entered into a multi year distribution agreement with The Binding Site Group Ltd. Under the terms of the

Affymetrix Axiom Genotyping Platform Selected by Toshiba - Analyst Blog
The Axiom Genotyping Solution platform of Affymetrix Inc. ( AFFX ) has been selected by Toshiba's Healthcare Company as the platform for its newly launched genotyping service. Affymetrix teamed up with Toshiba to custom design and help in manufacturing

I'm Selling Harvard Apparatus Regenerative Technology
It's time to sell Harvard Apparatus Regenerative Technology . My Special Situations portfolio acquired shares in the speculative research and development company before it was spun off from Harvard Bioscience last year. Why sell?

PerkinElmer (PKI) Posts In-Line Q3 Earnings, Revenue Miss - Analyst Blog
PerkinElmer Inc. ( PKI ) reported earnings of 57 cents per share in the third quarter of 2014, in line with the Zacks Consensus Estimate, but up 14% on a year over year basis. The earnings improvement was driven

Will Harvard Bioscience (HBIO) Continue to Surge Higher? - Tale of the Tape
Harvard Bioscience, Inc. ( HBIO ) has been on the move lately as the stock has risen by 9.1% in the past four weeks, and it is currently trading well above its 20 Day SMA. This is a pretty

Stem Cell Therapy May Prevent Heart Failure: 4 Companies to Watch
( Written by Alexander Crawford. Data sourced from Finviz.) A stem cell treatment for heart disease from Australias biotech firm Mesoblast Ltd lowered the risk of heart attack or cardiac death by 78% in a recent clinical trial. The study is a promising indication of the wide-ranging benefits that stem cell

Insider Buying Alert: 12 Stocks That Everyone Thinks Will Explode Higher
( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA. Short and insider data sourced from Yahoo! Finance. Institutional data sourced from Fidelity ) One way to pinpoint companies with bullish sentiment is by looking at company insider buying trends. After all, company insiders such as upper management